Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Background: Despite an increasing body of research highlighting their efficacy to treat a
broad range of medical conditions, psychedelic drugs remain a controversial issue among …
broad range of medical conditions, psychedelic drugs remain a controversial issue among …
Towards an understanding of psychedelic-induced neuroplasticity
Classic psychedelics, such as LSD, psilocybin, and the DMT-containing beverage
ayahuasca, show some potential to treat depression, anxiety, and addiction. Importantly …
ayahuasca, show some potential to treat depression, anxiety, and addiction. Importantly …
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Rationale Recent clinical trials are reporting marked improvements in mental health
outcomes with psychedelic drug-assisted psychotherapy. Objectives Here, we report on …
outcomes with psychedelic drug-assisted psychotherapy. Objectives Here, we report on …
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
The purpose of this paper is to provide an integrative review and offer novel insights
regarding human research with classic psychedelics (classic hallucinogens), which are …
regarding human research with classic psychedelics (classic hallucinogens), which are …
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt - Journal of psychopharmacology, 2017 - journals.sagepub.com
Previous attempts to identify a unified theory of brain serotonin function have largely failed to
achieve consensus. In this present synthesis, we integrate previous perspectives with new …
achieve consensus. In this present synthesis, we integrate previous perspectives with new …
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
F Palhano-Fontes, D Barreto, H Onias… - Psychological …, 2019 - cambridge.org
BackgroundRecent open-label trials show that psychedelics, such as ayahuasca, hold
promise as fast-onset antidepressants in treatment-resistant depression. MethodsTo test the …
promise as fast-onset antidepressants in treatment-resistant depression. MethodsTo test the …
[图书][B] Philosophy of psychedelics
C Letheby - 2021 - books.google.com
Recent clinical trials show that psychedelics such as LSD and psilocybin can be given safely
in controlled conditions, and can cause lasting psychological benefits with one or two …
in controlled conditions, and can cause lasting psychological benefits with one or two …
Classical psychedelics for the treatment of depression and anxiety: A systematic review
S Muttoni, M Ardissino, C John - Journal of affective disorders, 2019 - Elsevier
Background Depression and anxiety are prevalent psychiatric disorders that carry significant
morbidity. Pharmacological and psychosocial interventions are used to manage these …
morbidity. Pharmacological and psychosocial interventions are used to manage these …
Psychedelic communitas: intersubjective experience during psychedelic group sessions predicts enduring changes in psychological wellbeing and social …
Background: Recent years have seen a resurgence of research on the potential of
psychedelic substances to treat addictive and mood disorders. Historically and …
psychedelic substances to treat addictive and mood disorders. Historically and …
[HTML][HTML] Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
RL Carhart-Harris, M Bolstridge, J Rucker… - The Lancet …, 2016 - thelancet.com
Background Psilocybin is a serotonin receptor agonist that occurs naturally in some
mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for …
mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for …